New York, NY — New York, New York

New York, NY is a clinical research site located in New York, New York, United States 10022.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

New York, NY has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Macular Edema (DME), Myocardial Infarction, Comorbidity.

Sponsors: EyeBiotech Ltd., US Department of Veterans Affairs.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York, NY?

New York, NY has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York, NY conducted?

New York, NY has 3 clinical trials on record, with 1 currently active. Their work covers Diabetic Macular Edema (DME), Myocardial Infarction, Comorbidity.

Is New York, NY accredited by Crixeo Health?

New York, NY has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York, NY?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.